The Added Benefit of Intra‐Arterial Thrombolysis After Successful Recanalization by Endovascular Treatment: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Clinical Trials
European Journal of Neurology · 2025-07 · 32 (7)
DOI: 10.1111/ene.70270 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Neurology, online erschienen am 07.07.2025. Verfasst von Lina Palaiodimou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Neurology, 'Attikon' University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Thrombolytic Therapy, Endovascular Procedures, Ischemic Stroke, Fibrinolytic Agents. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite successful recanalization following endovascular thrombectomy (EVT) for acute ischemic stroke (AIS) with large‐vessel occlusion (LVO), many patients fail to achieve excellent functional outcomes. Post‐EVT intra‐arterial thrombolysis (IAT) has emerged as a potential adjunctive strategy to improve microvascular reperfusion and clinical recovery.
Methods
We conducted a systematic review and meta‐analysis of randomized‐controlled clinical trials (RCTs) comparing IAT plus best medical therapy (BMT) versus BMT alone in LVO‐AIS patients with successful recanalization post‐EVT. The primary efficacy outcome was 3‐month excellent functional outcome [modified Rankin Scale (mRS)‐score: 0–1]. Secondary efficacy outcomes included good functional outcome (mRS‐score: 0–2) and reduced disability (mRS‐score shift analysis) at 3 months. The primary safety outcome was symptomatic intracranial hemorrhage (sICH); secondary safety outcomes included any‐ICH and 3‐month all‐cause mortality. Subgroup and network meta‐analyses were performed evaluating the effects of different thrombolytic agents.
Results
Seven RCTs were included, comprising 1083 patients treated with IAT and 1048 patients treated with BMT alone. IAT was associated with higher likelihood of excellent functional outcome (RR: 1.23; 95% CI: 1.11–1.36; I 2 = 0%) and reduced disability at 3 months (common‐OR: 1.10; 95% CI: 1.03–1.18; I 2 = 0%) compared with BMT alone. Similar rates of 3‐month good functional outcome, 3‐month mortality, sICH and any‐ICH were observed. Although no significant subgroup differences emerged, in the network meta‐analysis alteplase ranked highest in efficacy [surface under the cumulative rank curve (SUCRA): 90%], followed by tenecteplase (61%) and urokinase (40%) in achieving 3‐month excellent functional outcome.
Conclusions
IAT improves excellent functional outcomes without compromising safety in LVO‐AIS patients with successful recanalization after EVT. Trial Registration The prespecified protocol of the present systematic review and meta‐analysis has been registered in the International Prospective Register of Ongoing Systematic Reviews PROSPERO (registration ID: CRD420251035903)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Neurology, 'Attikon' University Hospital, School of Medicine, National & Kapodistrian University of Athens, Athens, Greece.
- Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France.
- Department of Neurology, GHU-Paris Psychiatrie et Neurosciences, Paris, France.
- CHRU-Nancy, Department of Diagnostic and Therapeutic Neuroradiology, Université de Lorraine, Nancy, France.
- CHRU-Nancy, INSERM U1254, Université de Lorraine, CIC, Innovations Technologiques, Nancy, France.
- Interventional Neuroradiology Unit, Metropolitan Hospital, Piraeus, Greece.
ORCID-Profile: Benjamin Gory, Aikaterini Theodorou, Stavros Spiliopoulos, Michail Mantatzis, Nitin Goyal, Aristeidis H Katsanos, Georgios Tsivgoulis
Zitieren
APA
Palaiodimou, L., Papageorgiou, N. M., Turc, G., Gory, B., Theodorou, A., Bakola, E., Magoufis, G., Spiliopoulos, S., Mantatzis, M., Goyal, N., Themistocleous, M., Sarraj, A., Katsanos, A. H., Fischer, U., Alexandrov, A. V., & Tsivgoulis, G. (2025). The Added Benefit of Intra‐Arterial Thrombolysis After Successful Recanalization by Endovascular Treatment: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Clinical Trials. European Journal of Neurology, 32(7). https://doi.org/10.1111/ene.70270
Vancouver
Palaiodimou L, Papageorgiou NM, Turc G, Gory B, Theodorou A, Bakola E, et al. The Added Benefit of Intra‐Arterial Thrombolysis After Successful Recanalization by Endovascular Treatment: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Clinical Trials. European Journal of Neurology. 2025;32(7). doi:10.1111/ene.70270
BibTeX
@article{Palaiodimou2025,
author = {Palaiodimou, Lina and Papageorgiou, Nikolaos M and Turc, Guillaume and Gory, Benjamin and Theodorou, Aikaterini and Bakola, Eleni and Magoufis, George and Spiliopoulos, Stavros and Mantatzis, Michail and Goyal, Nitin and Themistocleous, Marios and Sarraj, Amrou and Katsanos, Aristeidis H and Fischer, Urs and Alexandrov, Andrei V and Tsivgoulis, Georgios},
title = {The Added Benefit of Intra‐Arterial Thrombolysis After Successful Recanalization by Endovascular Treatment: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Clinical Trials},
journal = {European Journal of Neurology},
year = {2025},
volume = {32},
number = {7},
doi = {10.1111/ene.70270}
}
EUVIMED